EUPENCLAV 250 12 TABLETS | ANTIBIOTIC FOR DOGS

EUPENCLAVE

250 TABLETS
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Per pill:
Amoxicillin (trihydrate) ………………………………. 200mg
Clavulanic acid (potassium clavulanate) ………. 50mg*
Erythrosine (E127) and other excipients qs
* In manufacturing an overdose of 1,5 mg is made.
3. PHARMACEUTICAL FORM
pills.
Uniform pink oblong scored tablet.
4. PHARMACOLOGICAL PROPERTIES
ATCvet code: QJ01CR02

gram-positive: Actinomyces spp.
Bacillus spp.
Clostridium spp.
Corynebacterium spp.
Staphylococcus spp.
Streptococcus spp.
Gram-negative: pasteurella spp.
Bacteroides spp.
Bordetella bronchiseptica
Escherichia coli
Fusobacterium spp.
haemophilus spp.
Klebsiella spp.
Proteus mirabilis
Salmonella spp.
In addition to Leptospira spp.
Penicillinase-producing strains are included.
Not indicated for infections caused by Pseudomonas.

5. CLINICAL DATA
5.1.- Target species:
Dogs
5.2.- Indications for use

EUPENCLAV 250 is indicated for the treatment of bacterial infections caused by
Amoxicillin-resistant beta-lactamase-producing strains.
• Respiratory tract infections
• Urogenital tract infections
• Infections of the digestive tract
• Infections of the skin and soft tissues
5.3.- Contraindications:
Do not administer to animals with a history of allergy to beta-lactam antibiotics.
Do not administer to rabbits, guinea pigs and hamsters.
5.4.- Adverse reactions
Mild gastrointestinal symptoms (diarrhea, vomiting).
Allergic reactions whose severity can range from simple hives
until a shock anaphylactic. In the event of allergic reactions, it should be
discontinue treatment and administer cortisone and adrenaline.
Suprainfections by non-susceptible microorganisms after prolonged use.
Occasionally it can produce hematic dyscrasias and colitis.
5.5.- Special precautions for use
Before any infectious process, bacteriological confirmation of the infection is recommended.
diagnosis and carrying out a sensitivity test of the bacteria causing the process.
Avoid direct contact with the product due to the risk of allergic reactions to the skin.
person who handles it.
5.6.- Use during pregnancy and lactation:
Studies in laboratory animals have not shown evidence of a teratogenic effect.
Use only according to the benefit / risk assessment made by the
responsible veterinarian.
5.7.- Interactions with other drugs and other forms of interaction
Chloramphenicol, sulfonamides and tetracyclines can inhibit the antibacterial effect of
penicillins due to the rapid onset of bacteriostatic action.

5.8.- Dosage and method of administration:
Administer orally.
The dose is 12,5 mg of antibiotic/kg of body weight twice a day. which is equivalent to
following dosage table:

It is recommended to administer the drug at the beginning of the meals, to minimize the
possible gastrointestinal effects.
The tablets can be given mixed with food.
Treatment duration:
It is recommended not to extend the treatment more than 5-7 days.
The dose and frequency of administration can be increased, according to veterinary criteria.
5.9.-Overdose:
The product has a wide margin of safety. In case of allergic reactions
severe, treatment should be interrupted and corticosteroids or adrenaline administered. In the
In all other cases, administer symptomatic treatment.
5.10.- Special warnings for each target species
Adjust the dose in animals with renal disorders.
5.11.- Waiting time
Not applicable
5.12.- Specific safety precautions that must be taken by the person who
administer or handle the medication:
Hypersensitivity (allergic) reactions may occur after skin contact.
Avoid direct contact with the product, taking specific precautions:
Wash hands after handling the product.
Do not smoke, eat or drink while handling the product.
If symptoms appear after exposure, such as skin rash, consult a doctor
and present these warnings. Swelling of the face, lips or eyes or difficulty
respiratory symptoms are more serious signs that require urgent medical attention.

6. PHARMACEUTICAL DATA
6.1.- Incompatibilities
They have not been described.
6.2.- Period of validity
3 years in the original packaging (blister).
6.3.- Special conservation precautions:
Store at a temperature below 30ºC.
6.4.- Nature and content of the container:
The product is presented in boxes with 1, 2, 10 or 20 blisters, containing 6 tablets each.
blister.
6.5.- Special precautions that must be observed to eliminate the drug
used and/or packaging
Any unused veterinary medicinal product or residues derived from it must be
disposed of in accordance with local regulations
7. NAME OR COMPANY NAME AND ADDRESS OR BUSINESS HEADQUARTERS OF THE HOLDER OF THE
MARKETING AUTHORIZATION
FATRO IBERICA SL
C/ Constitución 1, ground floor 3; 08960 Sant Just Desvern (Barcelona)
ADDITIONAL INFORMATION:
Marketing authorization number: 1821 ESP
Authorization / renewal date: December 21, 2007
Last text revision: February 19, 2009
Dispensing conditions: Subject to veterinary prescription

See technical sheet

EUPENCLAVE